Sorcin: mechanisms of action in cancer hallmarks, drug resistance and opportunities in therapeutics
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Soluble resistant related calcium binding protein (Sorcin) is crucial in cancer progression and drug resistance. Targeting Sorcin offers a promising therapeutic strategy for various cancers, improving patient outcomes.
Area Of Science
- Oncology
- Molecular Biology
- Biochemistry
Background
- Soluble resistant related calcium binding protein (Sorcin) is implicated in critical cancer processes.
- Sorcin's role extends to tumor progression, angiogenesis, metastasis, and multidrug resistance.
- Differential Sorcin expression correlates with cancer characteristics and patient survival.
Purpose Of The Study
- To review the mechanistic role of Sorcin in cancer development.
- To explore Sorcin's contribution to drug resistance.
- To discuss the clinical relevance and therapeutic potential of targeting Sorcin.
Main Methods
- Literature review of Sorcin's function in cancer.
- Analysis of Sorcin's involvement in angiogenesis and metastasis.
- Examination of Sorcin's impact on multidrug resistance.
Main Results
- Sorcin significantly influences tumor progression and metastasis.
- Sorcin expression levels are linked to patient prognosis and survival.
- Sorcin is a key factor in the development of drug-resistant cancers.
Conclusions
- Sorcin is a vital factor in cancer progression and drug resistance.
- Sorcin holds significant potential as a prognostic biomarker.
- Targeting Sorcin represents a promising therapeutic avenue for cancer treatment.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...